je.st
news
United Therapeutics submits pre-market approval application for use...
2014-12-26 10:50:53| Biotech - Topix.net
United Therapeutics Corporation announced today that Medtronic, Inc. has submitted a pre-market approval application to the U.S. Food and Drug Administration for the use of Medtronic's SynchroMedA II implantable drug infusion system for use with United Therapeutics' RemodulinA Injection delivered intravenously to patients with pulmonary arterial hypertension.
Tags: use
united
application
approval
Category:Biotechnology and Pharmaceuticals